| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.7B | $0.6B | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.0B | $0.0B | $0.1B |
| EPS (Basic) | $11.18 | $9.38 | $7.84 | $9.13 | $9.45 | $2.77 | $1.46 | $7.13 |
| EPS (Diluted) | $11.11 | $9.32 | $7.80 | $9.06 | $9.37 | $2.75 | $1.45 | $7.07 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.8B | $9.8B | $9.8B | $9.9B | $9.6B | $9.3B | $8.6B | $7.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.4B | $0.2B | $0.2B |
| Total Liabilities | $8.5B | $8.6B | $8.7B | $8.8B | $8.4B | $8.2B | $7.6B | $7.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $0.1B | $-0.0B | $0.1B | $-0.4B | $-0.4B | $-0.5B | $0.1B | $0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.2B | $-0.2B | $0.2B | $0.1B | $0.6B | $-0.2B | $-0.2B |